Weber Medicine & Clinical Case Reports


March 2015, Vol. 1 (1), ISSN:2449-1624

© Author(s) 2015. This work is distributed under the Creative Commons Attribution 3.0 License.

Research Article

Basic Application Research on a Method for Earliest Diagnosing Cancers

 Xu Han-You, MS.

School of Adult Higher Education 2014,
Zhengzhou University,
Department of Emergency Medicine,
Nanyang Wolong Hospital, Henan Province, China

 

Accepted 20th March, 2015; Available Online 21th March, 2015.


Abstract:

Background and Objective: The author of article created a molecular method for diagnosing cancers in earliest stage of carcinogenesis to treat the cancer well as the cancer early diagnosis has been poorly developed. Method: Referenced the scientific achievements of cancer research up to now, the author designed the novel creation.Then the value of method for earliest diagnosing cancers has been accepted by the international medical societies. Results: Using two different normal Rb protein antibodies and two different normal p53 antibodies, develops antigens and antibodies immune reactions respectively, with specimen of Rb proteins and p53 by special analysis method. After comparing the two reactions of Rb proteins' and the two reactions of p53's by application of Affinity Chromatography and Flow Scintillation Counter, the structures and functions of Rb genes and proteins, p53 genes and proteins can be judged. So the cancers can be diagnosed earliest. This invention for diagnosing cancers in earliest stage of carcinogenesis could be used for many kinds of cancers to be diagnosed in the same method. Conclusions: The new research method of molecular biology for earliest diagnosing cancers used by author in this paper is worth to be developed further and applied in clinical practice. It is first reported by the author in this article. Which is identified through a MEDLINE search of the English-language literature on the title or on the key words. The novel method has been proved valuable when it was accepted by international oncology societies.

[ View Abstract ]                        [ Full Text: PDF ]


 
 
Information for Authors
Author Guidelines

Manuscript Submission

Author FAQ

Copyright Policy

Publishing Ethics

Article Processing Fee

Join Us

As an Editor/Reviewer

Disclaimer